CSIMarket


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AMGN's Competition by Segment and its Market Share

(Most Recent Quarter in %)


COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN EPOGEN TM 27.75 % - 2.78 %
Abbvie Inc ABBV HUMIRA 64.66 % - 10.35 %
Abbott Laboratories ABT HUMIRA 15.59 % - 2.28 %
Abbott Laboratories ABT Established Pharmaceutical Products 18.66 % 14.97 % 2.73 %
Actavis Plc ACT Branded pharmaceutical products 77.1 % 94.6 % 4.41 %
Allergan plc AGN Skin Care 3.01 % - 0.08 %
Allergan plc AGN Tazorac, Zorac & Avage - - -
Bristol Myers Squibb Co BMY ORENCIA 11.89 % - 1.37 %
Celgene Corp CELG ABRAXANE 9.94 % - 0.65 %
Cephalon, Inc. CEPH Total Pain 28.42 % - 0.35 %
Cephalon, Inc. CEPH Oncology 5.3 % - 0.06 %
Johnson and Johnson JNJ PROCRIT 3.06 % - 1.55 %
Johnson and Johnson JNJ REMICADE 18.37 % - 9.28 %
Johnson and Johnson JNJ VELCADE 3.84 % - 1.94 %
Eli Lilly And Company LLY Oncology 17.37 % - 2.44 %
Eli Lilly And Company LLY Cardiovascular 15.32 % - 2.16 %
Merck and Co Inc MRK Zetia 6.48 % - 1.8 %
Pfizer Inc PFE Arthritis & pain 1.62 % - 0.6 %
Pfizer Inc PFE Oncology 2.14 % - 0.79 %
SCHERING-PLOUGH CORPORATION SGP Temodar 7.65 % - 0.61 %
Watson Pharmaceuticals Inc WPI Branded pharmaceutical products 18.01 % 34.24 % 0.3 %
Wyeth WYE ENBREL 9.37 % - 1.49 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN Aranesp TM-U.S. 13.05 % - 1.24 %
Abbvie Inc ABBV HUMIRA 64.66 % - 9.85 %
Abbott Laboratories ABT HUMIRA 15.59 % - 2.17 %
Abbott Laboratories ABT Established Pharmaceutical Products 18.66 % 14.97 % 2.6 %
Actavis Plc ACT Branded pharmaceutical products 77.1 % 94.6 % 4.19 %
Allergan plc AGN Skin Care 3.01 % - 0.08 %
Allergan plc AGN Tazorac, Zorac & Avage - - -
Bristol Myers Squibb Co BMY Other 45.27 % - 4.98 %
Bristol Myers Squibb Co BMY ORENCIA 11.89 % - 1.31 %
Celgene Corp CELG ABRAXANE 9.94 % - 0.62 %
Cephalon, Inc. CEPH Total Pain 28.42 % - 0.33 %
Cephalon, Inc. CEPH Oncology 5.3 % - 0.06 %
Johnson and Johnson JNJ PROCRIT 3.06 % - 1.47 %
Johnson and Johnson JNJ REMICADE 18.37 % - 8.83 %
Johnson and Johnson JNJ VELCADE 3.84 % - 1.85 %
Eli Lilly And Company LLY Oncology 17.37 % - 2.33 %
Eli Lilly And Company LLY Cardiovascular 15.32 % - 2.05 %
Merck and Co Inc MRK Zetia 6.48 % - 1.71 %
Pfizer Inc PFE Arthritis & pain 1.62 % - 0.57 %
Pfizer Inc PFE Oncology 2.14 % - 0.75 %
SCHERING-PLOUGH CORPORATION SGP Temodar 7.65 % - 0.58 %
Watson Pharmaceuticals Inc WPI Branded pharmaceutical products 18.01 % 34.24 % 0.29 %
Wyeth WYE ENBREL 9.37 % - 1.42 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN Aranesp TM-International 10.16 % - 0.97 %
Abbvie Inc ABBV HUMIRA 64.66 % - 9.88 %
Abbott Laboratories ABT HUMIRA 15.59 % - 2.18 %
Abbott Laboratories ABT Established Pharmaceutical Products 18.66 % 14.97 % 2.6 %
Actavis Plc ACT Branded pharmaceutical products 77.1 % 94.6 % 4.21 %
Allergan plc AGN Skin Care 3.01 % - 0.08 %
Allergan plc AGN Tazorac, Zorac & Avage - - -
Bristol Myers Squibb Co BMY Other 45.27 % - 4.99 %
Bristol Myers Squibb Co BMY ORENCIA 11.89 % - 1.31 %
Celgene Corp CELG ABRAXANE 9.94 % - 0.62 %
Cephalon, Inc. CEPH Total Pain 28.42 % - 0.33 %
Cephalon, Inc. CEPH Oncology 5.3 % - 0.06 %
Johnson and Johnson JNJ PROCRIT 3.06 % - 1.48 %
Johnson and Johnson JNJ REMICADE 18.37 % - 8.85 %
Johnson and Johnson JNJ VELCADE 3.84 % - 1.85 %
Eli Lilly And Company LLY Oncology 17.37 % - 2.33 %
Eli Lilly And Company LLY Cardiovascular 15.32 % - 2.06 %
Merck and Co Inc MRK Zetia 6.48 % - 1.71 %
Pfizer Inc PFE Arthritis & pain 1.62 % - 0.57 %
Pfizer Inc PFE Oncology 2.14 % - 0.76 %
SCHERING-PLOUGH CORPORATION SGP Temodar 7.65 % - 0.58 %
Watson Pharmaceuticals Inc WPI Branded pharmaceutical products 18.01 % 34.24 % 0.29 %
Wyeth WYE ENBREL 9.37 % - 1.43 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN NEUPOGEN TM-U.S. 6.58 % - 0.71 %
Actavis Plc ACT Branded pharmaceutical products 77.1 % 94.6 % 4.76 %
Allergan plc AGN Eye Care Pharmaceuticals 46.77 % - 1.41 %
Alexion Pharmaceuticals Inc ALXN Total - - 2.05 %
Biogen Inc BIIB AVONEX 29.25 % - 1.89 %
Biogen Inc BIIB TYSABRI 22.02 % - 1.42 %
Bristol Myers Squibb Co BMY SPRYCEL 10.1 % - 1.26 %
Celgene Corp CELG REVLIMID 62.85 % - 4.46 %
Celgene Corp CELG POMALYST, IMNOVID 11.09 % - 0.79 %
COVIDIEN LTD. COV Pharmaceutical Products 12.57 % - 1 %
Johnson and Johnson JNJ PROCRIT 3.06 % - 1.67 %
Merck and Co Inc MRK Remicade 4.52 % - 1.36 %
Pfizer Inc PFE All other 69.99 % - 28.08 %
Pfizer Inc PFE Other 2.43 % - 0.98 %
SCHERING-PLOUGH CORPORATION SGP Remicade 15.15 % - 1.31 %
Watson Pharmaceuticals Inc WPI Branded pharmaceutical products 18.01 % 34.24 % 0.33 %
Wyeth WYE Consumer Healthcare 12.72 % 6.89 % 2.19 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN NEUPOGEN TM-International 2.98 % - 0.28 %
Actavis Plc ACT Branded pharmaceutical products 77.1 % 94.6 % 4.16 %
Allergan plc AGN Eye Care Pharmaceuticals 46.77 % - 1.23 %
Alexion Pharmaceuticals Inc ALXN Total - - 1.79 %
Biogen Inc BIIB AVONEX 29.25 % - 1.65 %
Biogen Inc BIIB TYSABRI 22.02 % - 1.24 %
Bristol Myers Squibb Co BMY SPRYCEL 10.1 % - 1.1 %
Celgene Corp CELG REVLIMID 62.85 % - 3.89 %
Celgene Corp CELG ALKERAN 0.82 % - 0.05 %
Celgene Corp CELG POMALYST, IMNOVID 11.09 % - 0.69 %
COVIDIEN LTD. COV Pharmaceutical Products 12.57 % - 0.88 %
Johnson and Johnson JNJ PROCRIT 3.06 % - 1.46 %
Johnson and Johnson JNJ Other 9.08 % - 4.33 %
Merck and Co Inc MRK Remicade 4.52 % - 1.18 %
Pfizer Inc PFE All other 69.99 % - 24.51 %
Pfizer Inc PFE Other 2.43 % - 0.85 %
SCHERING-PLOUGH CORPORATION SGP Remicade 15.15 % - 1.14 %
Watson Pharmaceuticals Inc WPI Branded pharmaceutical products 18.01 % 34.24 % 0.29 %
Wyeth WYE Consumer Healthcare 12.72 % 6.89 % 1.92 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN NeulastaTM-U.S. 16.97 % - 5.04 %
Actavis Plc ACT Branded pharmaceutical products 77.1 % 94.6 % 13.09 %
Actavis Plc ACT Urology and Gastroenterology - - -
Celgene Corp CELG ALKERAN 0.82 % - 0.16 %
Johnson and Johnson JNJ Other 9.08 % - 13.62 %
Pfizer Inc PFE Urology 2.55 % - 2.81 %
Watson Pharmaceuticals Inc WPI Branded pharmaceutical products 18.01 % 34.24 % 0.9 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN NeulastaTM-International 4.68 % - 1.44 %
Actavis Plc ACT Branded pharmaceutical products 77.1 % 94.6 % 13.58 %
Actavis Plc ACT Urology and Gastroenterology - - -
Celgene Corp CELG ALKERAN 0.82 % - 0.17 %
Johnson and Johnson JNJ Other 9.08 % - 14.13 %
Pfizer Inc PFE Urology 2.55 % - 2.91 %
Watson Pharmaceuticals Inc WPI Branded pharmaceutical products 18.01 % 34.24 % 0.94 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN ENBREL TM-U.S. 22.05 % - 3.38 %
Abbvie Inc ABBV HUMIRA 64.66 % - 15.88 %
Abbott Laboratories ABT HUMIRA 15.59 % - 3.5 %
Abbott Laboratories ABT Established Pharmaceutical Products 18.66 % 14.97 % 4.19 %
Biogen Inc BIIB AVONEX 29.25 % - 2.68 %
Biogen Inc BIIB TYSABRI 22.02 % - 2.02 %
Bristol Myers Squibb Co BMY ORENCIA 11.89 % - 2.11 %
Cephalon, Inc. CEPH Total Pain 28.42 % - 0.53 %
Johnson and Johnson JNJ REMICADE 18.37 % - 14.23 %
Merck and Co Inc MRK Remicade 4.52 % - 1.93 %
Pfizer Inc PFE Arthritis & pain 1.62 % - 0.92 %
Pfizer Inc PFE Other 2.43 % - 1.38 %
SCHERING-PLOUGH CORPORATION SGP Remicade 15.15 % - 1.86 %
Wyeth WYE ENBREL 9.37 % - 2.29 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN ENBREL TM-International 1.25 % - 0.15 %
Abbvie Inc ABBV HUMIRA 64.66 % - 12.8 %
Abbott Laboratories ABT HUMIRA 15.59 % - 2.82 %
Abbott Laboratories ABT Established Pharmaceutical Products 18.66 % 14.97 % 3.37 %
Biogen Inc BIIB AVONEX 29.25 % - 2.16 %
Biogen Inc BIIB TYSABRI 22.02 % - 1.63 %
Bristol Myers Squibb Co BMY ORENCIA 11.89 % - 1.7 %
Celgene Corp CELG ABRAXANE 9.94 % - 0.81 %
Cephalon, Inc. CEPH Total Pain 28.42 % - 0.43 %
Cephalon, Inc. CEPH Oncology 5.3 % - 0.08 %
Johnson and Johnson JNJ REMICADE 18.37 % - 11.47 %
Johnson and Johnson JNJ VELCADE 3.84 % - 2.4 %
Eli Lilly And Company LLY Oncology 17.37 % - 3.02 %
Merck and Co Inc MRK Remicade 4.52 % - 1.55 %
Pfizer Inc PFE Arthritis & pain 1.62 % - 0.74 %
Pfizer Inc PFE Oncology 2.14 % - 0.98 %
Pfizer Inc PFE Other 2.43 % - 1.12 %
SCHERING-PLOUGH CORPORATION SGP Remicade 15.15 % - 1.5 %
Wyeth WYE ENBREL 9.37 % - 1.85 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN Other product sales - - -
Abbvie Inc ABBV HUMIRA 64.66 % - 7.63 %
Abbott Laboratories ABT HUMIRA 15.59 % - 1.68 %
Abbott Laboratories ABT Established Pharmaceutical Products 18.66 % 14.97 % 2.01 %
Bristol Myers Squibb Co BMY Other 45.27 % - 3.85 %
Bristol Myers Squibb Co BMY ORENCIA 11.89 % - 1.01 %
Bristol Myers Squibb Co BMY Eliquis 11.45 % - 0.98 %
Cephalon, Inc. CEPH Total Pain 28.42 % - 0.25 %
Johnson and Johnson JNJ REMICADE 18.37 % - 6.84 %
Eli Lilly And Company LLY Endocrinology 36.02 % - 3.74 %
Merck and Co Inc MRK Zocor 0.57 % - 0.12 %
Merck and Co Inc MRK CozaarHyzaar 1.54 % - 0.31 %
Merck and Co Inc MRK Januvia 10.38 % - 2.12 %
Mylan N v MYL Total 100 % 100 % 5.64 %
Pfizer Inc PFE Cardiovascular metabolic diseases 35.36 % - 9.67 %
Pfizer Inc PFE Arthritis & pain 1.62 % - 0.44 %
Pfizer Inc PFE Other 2.43 % - 0.67 %
Pfizer Inc PFE Cardiovascular & metabolic diseases 7.34 % - 2.01 %
SCHERING-PLOUGH CORPORATION SGP Temodar 7.65 % - 0.45 %
Wyeth WYE ENBREL 9.37 % - 1.1 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN Vectibix 1.53 % - 0.28 %
Celgene Corp CELG ABRAXANE 9.94 % - 1.2 %
Cephalon, Inc. CEPH Oncology 5.3 % - 0.12 %
Johnson and Johnson JNJ VELCADE 3.84 % - 3.55 %
Eli Lilly And Company LLY Oncology 17.37 % - 4.48 %
Merck and Co Inc MRK Other 59.33 % - 30.17 %
Pfizer Inc PFE Oncology 2.14 % - 1.45 %
Wyeth WYE ENBREL 9.37 % - 2.74 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN Sensipar TM - - -
Actavis Plc ACT Branded pharmaceutical products 77.1 % 94.6 % 9.2 %
Bristol Myers Squibb Co BMY SPRYCEL 10.1 % - 2.44 %
Celgene Corp CELG ABRAXANE 9.94 % - 1.36 %
Cephalon, Inc. CEPH Oncology 5.3 % - 0.13 %
Johnson and Johnson JNJ PROCRIT 3.06 % - 3.23 %
Johnson and Johnson JNJ VELCADE 3.84 % - 4.05 %
Eli Lilly And Company LLY Oncology 17.37 % - 5.11 %
Eli Lilly And Company LLY Cardiovascular 15.32 % - 4.51 %
Merck and Co Inc MRK Zetia 6.48 % - 3.75 %
Pfizer Inc PFE Oncology 2.14 % - 1.65 %
Watson Pharmaceuticals Inc WPI Branded pharmaceutical products 18.01 % 34.24 % 0.64 %
Wyeth WYE ENBREL 9.37 % - 3.12 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN Aranesp 13.99 % - 13.27 %
Abbott Laboratories ABT Biaxin clarithromycin 2.54 % - 3.53 %
Actavis Plc ACT Generic pharmaceutical products 7.64 % 3.4 % 4.14 %
HOSPIRA, INC. HSP Injectable Pharmaceutical 4 % - 0.9 %
Johnson and Johnson JNJ LEVAQUIN / FLOXIN 1.98 % - 9.47 %
SCHERING-PLOUGH CORPORATION SGP PEG-Intron 7.86 % - 5.95 %
SCHERING-PLOUGH CORPORATION SGP Rebetol 2.13 % - 1.62 %
Watson Pharmaceuticals Inc WPI Generic pharmaceutical products 60.15 % 59.12 % 9.63 %
Wyeth WYE ZOSYN TAZOCIN 5.06 % - 7.65 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN Prolia 18.16 % - 46.89 %
Merck and Co Inc MRK Fosamax 7.42 % - 53.11 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN Neulasta 65.92 % - 41.89 %
Abbott Laboratories ABT Biaxin clarithromycin 2.54 % - 2.36 %
Actavis Plc ACT Generic pharmaceutical products 7.64 % 3.4 % 2.77 %
HOSPIRA, INC. HSP Injectable Pharmaceutical 4 % - 0.6 %
Johnson and Johnson JNJ LEVAQUIN / FLOXIN 1.98 % - 6.35 %
SCHERING-PLOUGH CORPORATION SGP PEG-Intron 7.86 % - 3.99 %
SCHERING-PLOUGH CORPORATION SGP Rebetol 2.13 % - 1.08 %
Watson Pharmaceuticals Inc WPI Generic pharmaceutical products 60.15 % 59.12 % 6.45 %
Wyeth WYE ZOSYN TAZOCIN 5.06 % - 5.12 %
COMPANY NAME TICKER SEGMENT NAME OF TOT. REV. OF TOT. INC. MARKET SHARE
Amgen Inc AMGN ENBREL 41.4 % - 3.49 %
Abbvie Inc ABBV HUMIRA 64.66 % - 8.72 %
Abbott Laboratories ABT HUMIRA 15.59 % - 1.92 %
Abbott Laboratories ABT Established Pharmaceutical Products 18.66 % 14.97 % 2.3 %
Allergan plc AGN Eye Care Pharmaceuticals 46.77 % - 1.09 %
Biogen Inc BIIB AVONEX 29.25 % - 1.47 %
Biogen Inc BIIB TYSABRI 22.02 % - 1.11 %
Biogen Inc BIIB TECFIDERA 42 % - 2.11 %
Biogen Inc BIIB PLEGRIDY 3.54 % - 0.18 %
Bristol Myers Squibb Co BMY ORENCIA 11.89 % - 1.16 %
COVIDIEN LTD. COV Pharmaceutical Products 12.57 % - 0.78 %
Johnson and Johnson JNJ REMICADE 18.37 % - 7.81 %
Merck and Co Inc MRK Remicade 4.52 % - 1.06 %
Pfizer Inc PFE Arthritis & pain 1.62 % - 0.51 %
Pfizer Inc PFE All other 69.99 % - 21.87 %
Pfizer Inc PFE Other 2.43 % - 0.76 %
SCHERING-PLOUGH CORPORATION SGP Remicade 15.15 % - 1.02 %
Wyeth WYE ENBREL 9.37 % - 1.26 %
Wyeth WYE Consumer Healthcare 12.72 % 6.89 % 1.71 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CZNI's Profile

Stock Price

CZNI's Financials

Business Description

Fundamentals

Charts & Quotes

CZNI's News

Suppliers

CZNI's Competitors

Customers & Markets

Economic Indicators

CZNI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071